- Home
- CMP vs NBTX Comparison
CMP vs NBTX Comparison
Compare CMP & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMP | NBTX |
|---|---|---|
| Founded | 1993 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2003 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CMP | NBTX |
|---|---|---|
| Price | $23.05 | $29.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $21.50 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 475.4K | 52.2K |
| Earning Date | 05-06-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.25 | $11.73 |
| P/E Ratio | $55.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.60 | $2.99 |
| 52 Week High | $27.00 | $41.89 |
Technical Indicators
Market Signals| Indicator | CMP | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 49.56 |
| Support Level | $20.66 | $20.11 |
| Resistance Level | $26.40 | $30.23 |
| Average True Range (ATR) | 1.03 | 1.99 |
| MACD | 0.08 | -0.69 |
| Stochastic Oscillator | 51.03 | 13.69 |
Price Performance
Historical ComparisonAbout CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.